InsidersTradesSigma
Total declarations
Company
▲ Purchases (12 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
12
Disclosed sells
1
T+90 hit rate
80%
T+90 mean return
+16.8%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Thermopylae Holdings Ltd.. Director active across 1 company, notably AbCellera Biologics Inc.. In total, 17 reports have been recorded. Split: 12 buys · 1 sell. Total volume traded: €130.7m. Activity tracked since 9 June 2021. The latest transaction was filed on 27 February 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Thermopylae Holdings Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
38,000 shares@ US$3.440.1% of flowCommon SharesSEC:0001834449-26-000004:0
Canonical exit: 28 May 2026 (T+90)
177,457 shares@ US$3.270.4% of flowCommon SharesSEC:0001834449-26-000002:0
Canonical exit: 27 May 2026 (T+90)
225,000 shares0Common SharesSEC:0001834449-25-000004:0
343,631 shares@ US$2.160.3% of flowCommon SharesSEC:0001628280-25-012154:0
Canonical exit: 9 Jun 2025 (T+90)
286,000 shares0Common SharesSEC:0001628280-24-050097:0
283,516 shares@ US$2.610.3% of flowCommon SharesSEC:0001628280-24-038829:0
Canonical exit: 27 Nov 2024 (T+90)
210,000 shares0Common SharesSEC:0001703057-23-000049:0
153,000 shares@ US$6.52110.4% of flowCommon SharesSEC:0001209191-23-032481:0
Canonical exit: 24 Aug 2023 (T+90)
85,102 shares@ US$10.09670.3% of flowCommon SharesSEC:0001209191-22-062090:0
Canonical exit: 16 Mar 2023 (T+90)
70,000 shares0Common SharesSEC:0001209191-22-056271:0
200,000 shares@ US$11.46230.9% of flowCommon SharesSEC:0001209191-22-046998:0
Canonical exit: 17 Nov 2022 (T+90)
54,915 shares@ US$8.03180.034% mcap0.2% of flowCommon SharesSEC:0001209191-22-036884:0
Canonical exit: 11 Sept 2022 (T+90)
64,545 shares@ US$7.49810.036% mcap0.2% of flowCommon SharesSEC:0001209191-22-034983:0
Canonical exit: 4 Sept 2022 (T+90)
300,000 shares@ US$7.25510.17% mcap0.9% of flowCommon SharesSEC:0001209191-22-029541:0
Canonical exit: 11 Aug 2022 (T+90)
1,408,468 shares@ US$6.40540.70% mcap3.7% of flowCommon SharesSEC:0001209191-22-029092:0
Canonical exit: 10 Aug 2022 (T+90)
202,960 shares@ US$14.76112.0% of flowCommon SharesSEC:0001209191-21-064377:0
Canonical exit: 9 Feb 2022 (T+90)
5,598,420 shares@ US$24.0384.5% of flowCommon SharesSEC:0000899243-21-022994:0
17 of 17 declarations
About Thermopylae Holdings Ltd.
Thermopylae Holdings Ltd. is a declarant linked to AbCellera Biologics Inc. on XNAS. Across 17 filings in total, the 17 sampled filings run from 2021-06-10 to 2026-03-02, with EUR 20237652 of buys and EUR 110433413 of sells, and the modal transaction nature is Acquisition.
